SMO and cancer: Later modifications of IPI-269609 yielded saridegib, a potent SMO inhibitor which completely abrogated tumor regrowth in B837Tx medulloblastoma xenograft models following treatment with saridegib, indicating complete elimination of cancer cells [516].